OSSAPIG-NF-NF1(FS41) MINIATURE SWINE (nf1 hindiii restriction fragment length polymorphism- rflp positive for nf1-r1947 stop codon in ossabaw breed swine not applicable

OssaPig-NF-NF1(FS41) Miniature Swine by

Drug Labeling and Warnings

OssaPig-NF-NF1(FS41) Miniature Swine by is a Other medication manufactured, distributed, or labeled by Recombinetics, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

STATEMENT OF IDENTITY

Identity: Transcription activator-like effector nuclease (TALEN) edit and homology dependent repair in Ossabaw breed porcine fetal fibroblasts to introduce a C>T base substitution at base pair 43,530,892 and insertion of five nucleotides between base pairs 43,308,890 and 43,530,889 of Sus scrofa chromosome 12 (NC_010454.4). The base substitution generates a premature stop codon in the coding sequence for the neurofibromin protein and the five nucleotide insertion generates a HindIII restriction enzyme site used to genotype progeny from gene edited founders.

HEALTH CLAIM

Claim: Loss of NF1 gene function as a result of this gene edit in the Ossabaw breed of swine produces symptoms consistent with the National Institutes of Health (NIH) criteria for diagnosis of Neurofibromatosis Type I disease in humans.

CONTRAINDICATIONS

Limitations: This is a model of progressive disease. Some of the disease symptoms associated with Neurofibromatosis Type I disease in humans take time to develop, and like the human disease, are variable in presentation from animal to animal.

INDICATIONS & USAGE

Product Use: Model animals and/or materials derived from these animals are intended for purchase only under license agreement with Recombinetics, Inc., and solely for use in connection with the specific licensed biomedical research.

INDICATIONS & USAGE

Conditions of Use: This model animal and any products derived from it are for biomedical research purposes only and not for use in humans. This is an investigational animal. Edible products of investigational animals are not to be used for food unless authorization has been granted by the U.S. Food and Drug Administration or by the U.S. Department of Agriculture.

WARNINGS AND PRECAUTIONS

Caution. This intentionally genetically altered animal and any products derived from it are for biomedical research purposes only and are not for use in humans or as human or animal food.
OssaPig-NF-NF1(FS41) animals are not for resale. No reproduction, distribution, transportation, or other third party transfer is allowed by the purchaser unless specifically agreed to in writing by Recombinetics, Inc.
OssaPig-NF-NF1(FS41) animals, or any materials derived from the OssaPig-NF-NF1(FS41) animals, are not intended to enter the human or animal food supply.
OssaPig-NF-NF1(FS41) animals shall be euthanized in accordance with all applicable regulatory or industry standards, and all animal remains must be disposed of by incineration. Purchaser must maintain detailed records accounting for the location of all OssaPig-NF-NF1(FS41) animals, and all materials derived from the OssaPig-NF-NF1(FS41) animals, from the time the animals are delivered to Purchaser through disposition by incineration. Final disposition notification must be made to Recombinetics, Inc.

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

OSSAPIG-NF-NF1(FS41) MINIATURE SWINE 
nf1 hindiii restriction fragment length polymorphism (rflp) positive for nf1-r1947 stop codon in ossabaw breed swine not applicable

Product Information
Product Type	RECOMBINANT DEOXYRIBONUCLEIC ACID CONSTRUCT LABEL	Item Code (Source)	NDC: 86086-002
Route of Administration	NOT APPLICABLE

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SUS SCROFA G.(NC_010454.4)43530892C>T + 43530890_43530889insAGCTT IN OSSABAW MINIATURE SWINE (UNII: FY9NU6D8JD) (SUS SCROFA G.(NC_010454.4)43530892C>T + 43530890_43530889insAGCTT IN OSSABAW MINIATURE SWINE - UNII:FY9NU6D8JD)	SUS SCROFA G.(NC_010454.4)43530892C>T + 43530890_43530889insAGCTT IN OSSABAW MINIATURE SWINE	1 [arb'U]  in 1 [arb'U]

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 86086-002-01	1 [arb'U] in 1 NOT APPLICABLE

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		06/03/2019

Labeler - Recombinetics, Inc. (829874523)

Registrant - Recombinetics, Inc. (829874523)

Establishment
Name	Address	ID/FEI	Business Operations
Recombinetics, Inc.		080987344	manufacture